Cargando…
Celecoxib Reverse Invasion and Metastasis of Gastric Cancer through Lnc_AC006548.28-miR-223-LAMC2 Pathway
Celecoxib, a specific cyclooxygenase-2 (COX-2) inhibitor, is a traditional nonsteroidal antipyretic analgesic and anti-inflammatory drug commonly used in clinic, which has inhibitory effect on colorectal cancer, gastric cancer, and other malignant tumors. This study showed that Celecoxib could signi...
Autores principales: | Jin, Guohua, Zhang, Jianguang, Cao, Tingting, Zhu, He, Shi, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167023/ https://www.ncbi.nlm.nih.gov/pubmed/35669642 http://dx.doi.org/10.1155/2022/6140727 |
Ejemplares similares
-
Retracted: Celecoxib Reverse Invasion and Metastasis of Gastric Cancer through Lnc_AC006548.28-miR-223-LAMC2 Pathway
por: Intelligence and Neuroscience, Computational
Publicado: (2023) -
Cluster emission in the radioactive decay of 223Ac
por: Steyn, G F, et al.
Publicado: (2010) -
LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein
por: Liang, Yan, et al.
Publicado: (2018) -
Variants in LAMC3 Causes Occipital Cortical Malformation
por: Qian, Xiaohang, et al.
Publicado: (2021) -
LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)